IL-6 is reportedly secreted by tumor cells and cancer-associated fibroblasts in response to platinum treatment, enhancing chemoresistance via STAT3-mediated enrichment of cancer stem cells [41]. The gene discussed is STAT3; the disease is neoplasm.